Valerie Rusch

Automated segmentation of mesothelioma volume on CT scan

Lawrence H. Schwartz, Fan Liu, Binsheng Zhao, 2005, SPIE Medical Imaging.

Prevalence and mortality of acute lung injury and ARDS after lung resection.

Valerie Rusch, V. Rusch, N. Halpern, 2006, Chest.

The IASLC Lung Cancer Staging Project: Summary of Proposals for Revisions of the Classification of Lung Cancers with Multiple Pulmonary Sites of Involvement in the Forthcoming Eighth Edition of the TNM Classification

Fergus Gleeson, Heber MacMahon, Jin Mo Goo, 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

An integrated genomic analysis of lung cancer reveals loss of DUSP4 in EGFR-mutant tumors

Chris Sander, William Pao, Stephen Broderick, 2009, Oncogene.

Bronchioloalveolar pathologic subtype and smoking history predict sensitivity to gefitinib in advanced non-small-cell lung cancer.

William Pao, Valerie Rusch, Christopher Azzoli, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Molecular Characteristics Predict Clinical Outcomes: Prospective Trial Correlating Response to the EGFR Tyrosine Kinase Inhibitor Gefitinib with the Presence of Sensitizing Mutations in the Tyrosine Binding Domain of the EGFR Gene

William Pao, Ronglai Shen, Marc Ladanyi, 2011, Clinical Cancer Research.

Comprehensive Histologic Assessment Helps to Differentiate Multiple Lung Primary Nonsmall Cell Carcinomas From Metastases

William Pao, Valerie Rusch, Charuhas Deshpande, 2009, The American journal of surgical pathology.

Identification of KIF5B-RET and GOPC-ROS1 Fusions in Lung Adenocarcinomas through a Comprehensive mRNA-Based Screen for Tyrosine Kinase Fusions

Tatsuo Ito, Udayan Guha, Marc Ladanyi, 2012, Clinical Cancer Research.

Current Status and Future Perspectives on Neoadjuvant Therapy in Lung Cancer

Lawrence H. Schwartz, Donald A. Berry, Janis M. Taube, 2018, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib

William Pao, Stephen Broderick, Lu Wang, 2007, Proceedings of the National Academy of Sciences.

EGFR mutations in lung adenocarcinomas: clinical testing experience and relationship to EGFR gene copy number and immunohistochemical expression.

William Pao, Marc Ladanyi, Valerie Rusch, 2008, The Journal of molecular diagnostics : JMD.

Neoadjuvant PD‐1 Blockade in Resectable Lung Cancer

Stephen Broderick, John-William Sidhom, Valsamo Anagnostou, 2018, The New England journal of medicine.